David Kendra writes:
> From BIOSCI-REQUEST at net.bio.net Mon Nov 28 14:28:31 1994
> To: immunology at net.bio.net> From: dkendra at MR.NET ("David Kendra")
> Subject: Commercial Source of Ab Recognizing Thioredoxin
> Date: 28 Nov 1994 12:05:03 -0800
> Sender: daemon at net.bio.net> Message-ID: <62670.dkendra at MR.Net>
> Reply-To: <dkendra at MR.NET>
> NNTP-Posting-Host: net.bio.net
>> One of my colleagues is making a fusion between a small peptide (~3000MW)
> and thioredoxin and would like a commercial source of antibodies against
> thioredoxin to make an affinity column.
If non, he could biotinylate the thioredoxin first then perform the
fusion, isolate the fused complex by avidin column